Celgene Corp (NASDAQ:CELG)
CAPS Rating:
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
RSS Headlines
Fool UK
Recs
Some insiders traded hedge funds based on inside information and were caught the Co. withdrew its application to expand its application for the use of Revlimid in Europe made purchases of small Co's at substantial gains